Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
AZD9829 for Blood Cancers
Recruiting1 awardPhase 1 & 2
Columbus, Ohio
This trial is testing a new drug called AZD9829. It will be given through a vein to patients with certain types of blood cancers. The study will determine the best dose of the drug to
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.